Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

Rafael Alencar

Articles by Rafael Alencar

CMED: The ‘Curupira’ of Brazil’s Pharma Market

ByMariana Torgal,Rafael Alencar,Catarina Costa Pinheiro

February 21st 2017

Outlining one country’s unique price-setting model for novel drugs-and the resulting pre-launch strategies for manufacturers.

Latest Updated Articles

CMED: The ‘Curupira’ of Brazil’s Pharma Market
Published: February 21st 2017 | Updated:

Trending on PharmExec

FDA to Take Action Against Mass-Marketing of Illegal Copycat Drugs: Report

Everything to Know About TrumpRx in 2026

Novo Nordisk Launches First Super Bowl Commercial for Wegovy Pill

Pharmaceutical Executive Daily: The Launch of TrumpRx